Posted On: October 3, 2023

Stock Report: IPCALAB(NSE) 29 Sep 2023

Outlook: Bullish

Sector: Healthcare 

Industry: Drug Manufacturers – Specialty & Generic 

Ipca Laboratories Ltd is a specialty and generic drug manufacturing company. The company operates multiple subsidiaries with revenue generation split roughly between India and the rest of the world. Ipca’s products are exported to more than 100 countries across the globe. Ipca has only one reportable primary business segment, pharmaceuticals. 

#xCalData predicts that # IPCALAB will continue its bullish phase over the next five days and trend within the range of 920 to 978. 

 
In comparison to the previous month, the price of the stock has experienced an increase of 5.32% indicating a bullish. . 

The Stock has doubled twice since 06 Feb 2015 and took an average of 3.3 years to double. 

The stock has shown seasonality trend in the past. 

Reviewing the returns for the past 5 years for the same week, we see the stock has given negative returns in 5 years in the past. 

Majority of the technical ratios trend towards Bullish side of the spectrum. 

Collectively, xCalData suggests the stock would be in Bullish zone for next 5 days. 

#xCalData is an exceptional app available for Android devices that offers unbiased insights into stocks, allowing investors to make informed decisions. With its user-friendly interface and comprehensive features, xCalData provides a valuable resource for anyone interested in the stock market.  Download the app from google play. 

For Actionable Intelligence, subscribe to xCalData app on Android devices: https://tinyurl.com/downloadxCalData

Similar Posts